Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
By Joshua A. Beckman, M. Creager, Peter Libby. Journal of the American Medical Association (JAMA), 2002
3,010 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/d44b1ec24015f7c5f0fcdd24daeecce135e84f58
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Epidemiology of Sudden Cardiac Death: Clinical and Research Implications (2008, background): “However, there may be diabetes-specific accelerated forms of atherosclerosis with enhanced thrombogenicity (57).”
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies (2011, neutral): “7 Diff erent uncertainties apply to measures of dysglycaemia in people without diabetes.”
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. (2007, neutral): “However, the bioavailability of endothelium-derived nitric oxide is reduced in individuals with diabetes mellitus (22).”
- Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I (2003, background): “Both insulin resistance and hyperglycemia participate to the pathogenesis of this prothrombotic state.(81) Insulin resistance”
- Depression as a disease of modernity: explanations for increasing prevalence (2012, background): “Drastic changes in daily life over the past century are fueling the growing burden of chronic diseases, including atherosclerosis, hormone-related and gastrointestinal cancers, osteoporosis, and type 2 diabetes mellitus (Beckman et al., 2002; Eaton and III, 2004; Mokdad et al., 2001; Omenn, 2010; Sm”
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020, neutral): “T2DM also increases risk of major CVD events ~twofold 114–116 and”